CM
RVMDW icon

Caption Management’s Revolution Medicines Inc Warrant RVMDW Stock Holding History

Caption Management’s Portfolio RVMDW Stock Details RVMDW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$927K Buy
517,685
+417,685
+418% +$809K 0.01% 1045
2025
Q4 		$94K Buy
+100,000
New +$56.4K ﹤0.01% 1444

Other funds holding RVMDW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LC
Lunate Capital Al Maryah Island, Abu Dhabi, United Arab Emirates $196M AUM 84.21% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Caption Management's RVMDW Position: Q1 2026 in Review

Caption Management increased its Revolution Medicines Inc Warrant (RVMDW) stake by 418% in Q1 2026, buying an estimated $809K and bringing the position to 517,685 shares worth $927K. The position accounts for 0.01% of the portfolio, ranked #1045.

Caption Management first reported a position in RVMDW in Q4 2025 and has held it in 2 quarters since. 23 funds tracked by Wall St. Rank hold RVMDW as of Q1 2026.

  • Caption Management held 517,685 shares of Revolution Medicines Inc Warrant worth $927K as of Q1 2026.
  • Caption Management bought 417,685 Revolution Medicines Inc Warrant shares in Q1 2026, an estimated $809K.
  • Revolution Medicines Inc Warrant made up 0.01% of Caption Management's portfolio in Q1 2026, its #1045 holding.
  • Caption Management first reported a position in Revolution Medicines Inc Warrant in Q4 2025 and has held it in 2 quarters since.
  • 23 funds tracked by Wall St. Rank held Revolution Medicines Inc Warrant as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.